Product Overview
[Drug Name]
Generic Name: Colloidal Bismuth Tartrate Capsules
Trade Name: HuaNaDeLe Colloidal Bismuth Tartrate Capsules 165mg*12 Capsules
Pinyin Full Code: HuaNaDeLe JiaoTiJiuShiSuanZuoJiaoNang 165mg*12Li
[Main Ingredients]
The main ingredient of this product is colloidal bismuth tartrate.
[Properties]
This product is a capsule containing a light yellow powder.
[Indications/Main Functions]
Treatment of peptic ulcers, particularly Helicobacter pylori-related ulcers. It can also be used for chronic colitis, diarrhea caused by ulcerative colitis, and chronic superficial and atrophic gastritis.
[Specifications]
165mg*12 Capsules
[Dosage and Administration]
Oral administration. 165mg (3 capsules) four times daily, one hour before each of the three meals and at bedtime.
[Adverse Reactions]
Nausea, constipation, and other gastrointestinal symptoms may occur occasionally.
[Contraindications]
This product is contraindicated in patients with allergies or renal impairment.
[Drug Interactions]
This product should not be taken with antacids, milk, or H2 receptor blockers, as this may reduce its effectiveness.
[Precautions]
1. Do not use this product continuously for more than 7 days. If symptoms do not improve, consult a physician or pharmacist. 2. Consult a physician or pharmacist regarding dosage for children. 3. Do not take other bismuth preparations while taking this product, and this product should not be taken in large quantities or over a long period of time. 4. If an overdose or severe adverse reactions occur, seek medical attention immediately. 5. This product is contraindicated in patients with allergies and should be used with caution in those with allergic conditions. 6. Do not use if its properties change. 7. Keep this product out of reach of children. 8. Children must be supervised by an adult before use. 9. If you are taking other medications, consult a physician or pharmacist before using this product. Please read the instructions carefully and use according to your physician's instructions.
[Use in Children]
Unclear.
[Use in Elderly Patients]
Unclear.
[Overdose]
Long-term use of this drug in high doses may cause bismuth poisoning, manifested by dark brown discoloration of the skin. Immediately discontinue use and seek appropriate treatment.
[Pharmacology and Toxicology]
Unknown.
